20-46051785-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_020708.5(SLC12A5):​c.2292G>T​(p.Gly764Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.013 in 1,608,856 control chromosomes in the GnomAD database, including 182 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G764G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.011 ( 15 hom., cov: 31)
Exomes 𝑓: 0.013 ( 167 hom. )

Consequence

SLC12A5
NM_020708.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.280

Publications

3 publications found
Variant links:
Genes affected
SLC12A5 (HGNC:13818): (solute carrier family 12 member 5) K-Cl cotransporters are proteins that lower intracellular chloride concentrations below the electrochemical equilibrium potential. The protein encoded by this gene is an integral membrane K-Cl cotransporter that can function in either a net efflux or influx pathway, depending on the chemical concentration gradients of potassium and chloride. The encoded protein can act as a homomultimer, or as a heteromultimer with other K-Cl cotransporters, to maintain chloride homeostasis in neurons. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Sep 2008]
SLC12A5 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 34
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
  • epilepsy of infancy with migrating focal seizures
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, idiopathic generalized, susceptibility to, 14
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Illumina, Ambry Genetics
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 20-46051785-G-T is Benign according to our data. Variant chr20-46051785-G-T is described in ClinVar as Benign. ClinVar VariationId is 475647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.28 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0108 (1649/152294) while in subpopulation NFE AF = 0.0148 (1006/68022). AF 95% confidence interval is 0.014. There are 15 homozygotes in GnomAd4. There are 838 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC12A5NM_020708.5 linkc.2292G>T p.Gly764Gly synonymous_variant Exon 18 of 26 ENST00000243964.7 NP_065759.1 Q9H2X9-2
SLC12A5NM_001134771.2 linkc.2361G>T p.Gly787Gly synonymous_variant Exon 18 of 26 NP_001128243.1 Q9H2X9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC12A5ENST00000243964.7 linkc.2292G>T p.Gly764Gly synonymous_variant Exon 18 of 26 1 NM_020708.5 ENSP00000243964.4 Q9H2X9-2

Frequencies

GnomAD3 genomes
AF:
0.0108
AC:
1650
AN:
152176
Hom.:
15
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00239
Gnomad AMI
AF:
0.0296
Gnomad AMR
AF:
0.00785
Gnomad ASJ
AF:
0.0138
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00539
Gnomad FIN
AF:
0.0274
Gnomad MID
AF:
0.0159
Gnomad NFE
AF:
0.0148
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.0118
AC:
2875
AN:
244606
AF XY:
0.0119
show subpopulations
Gnomad AFR exome
AF:
0.00188
Gnomad AMR exome
AF:
0.00616
Gnomad ASJ exome
AF:
0.0170
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0271
Gnomad NFE exome
AF:
0.0146
Gnomad OTH exome
AF:
0.0170
GnomAD4 exome
AF:
0.0132
AC:
19224
AN:
1456562
Hom.:
167
Cov.:
34
AF XY:
0.0129
AC XY:
9354
AN XY:
724628
show subpopulations
African (AFR)
AF:
0.00202
AC:
67
AN:
33190
American (AMR)
AF:
0.00707
AC:
310
AN:
43846
Ashkenazi Jewish (ASJ)
AF:
0.0153
AC:
396
AN:
25946
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39136
South Asian (SAS)
AF:
0.00578
AC:
494
AN:
85472
European-Finnish (FIN)
AF:
0.0251
AC:
1337
AN:
53214
Middle Eastern (MID)
AF:
0.0188
AC:
108
AN:
5752
European-Non Finnish (NFE)
AF:
0.0142
AC:
15724
AN:
1109820
Other (OTH)
AF:
0.0131
AC:
788
AN:
60186
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
985
1969
2954
3938
4923
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
576
1152
1728
2304
2880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0108
AC:
1649
AN:
152294
Hom.:
15
Cov.:
31
AF XY:
0.0113
AC XY:
838
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.00238
AC:
99
AN:
41558
American (AMR)
AF:
0.00784
AC:
120
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0138
AC:
48
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.00539
AC:
26
AN:
4824
European-Finnish (FIN)
AF:
0.0274
AC:
291
AN:
10614
Middle Eastern (MID)
AF:
0.0137
AC:
4
AN:
292
European-Non Finnish (NFE)
AF:
0.0148
AC:
1006
AN:
68022
Other (OTH)
AF:
0.0128
AC:
27
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
74
147
221
294
368
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0124
Hom.:
13
Bravo
AF:
0.00858
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC12A5: BP4, BP7, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Developmental and epileptic encephalopathy, 34 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
4.8
DANN
Benign
0.69
PhyloP100
-0.28
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79522550; hg19: chr20-44680424; API